» Articles » PMID: 16375853

Renewal of Cue-elicited Urge to Smoke: Implications for Cue Exposure Treatment

Overview
Journal Behav Res Ther
Specialty Psychology
Date 2005 Dec 27
PMID 16375853
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of cue exposure therapy are limited, because renewal after extinction is an important source of relapse. In this study, 33 smokers were exposed to a cue predicting smoking availability and a cue predicting smoking unavailability in one context (acquisition context A). Following extinction in another context (extinction context B), a test for renewal took place in the original acquisition context A (i.e. ABA renewal). Urge to smoke was measured using a Visual Analogue Scale. Renewal of differential conditioned urge responding occurred when participants were tested in the acquisition context, while differential urge responding remained extinguished when tested in the extinction context. This experiment provides evidence that ABA renewal occurred in smokers. Clinical implications are discussed.

Citing Articles

Transcranial direct current stimulation associated with physical exercise can help smokers to quit smoking: a randomized controlled trial.

da Silva G, Silva L, Filho E, Damasceno M, Monte-Silva K, Ximenes-da-Silva A Sci Rep. 2025; 15(1):8623.

PMID: 40074739 PMC: 11903688. DOI: 10.1038/s41598-025-85877-4.


Use of the overexpectation effect to reduce conditioned seeking behavior controlled by nicotine.

Barrett S, Tracy M, Bevins R Psychon Bull Rev. 2024; 31(6):2758-2766.

PMID: 38769272 DOI: 10.3758/s13423-024-02524-1.


Virtual Reality Technology Use in Cigarette Craving and Smoking Interventions (I "Virtually" Quit): Systematic Review.

Keijsers M, Vega-Corredor M, Tomintz M, Hoermann S J Med Internet Res. 2021; 23(9):e24307.

PMID: 34533471 PMC: 8486991. DOI: 10.2196/24307.


Drug-Induced Conditioned Place Preference and Its Practical Use in Substance Use Disorder Research.

McKendrick G, Graziane N Front Behav Neurosci. 2020; 14:582147.

PMID: 33132862 PMC: 7550834. DOI: 10.3389/fnbeh.2020.582147.


Considering Drug-Associated Contexts in Substance Use Disorders and Treatment Development.

LeCocq M, Randall P, Besheer J, Chaudhri N Neurotherapeutics. 2020; 17(1):43-54.

PMID: 31898285 PMC: 7007469. DOI: 10.1007/s13311-019-00824-2.